(Q40761190)

English

Effects of receptor tyrosine kinase inhibitor A47 on estrogen and growth factor-dependent breast cancer cell proliferation and apoptosis in vitro

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

Effects of receptor tyrosine kinase inhibitor A47 on estrogen and growth factor-dependent breast cancer cell proliferation and apoptosis in vitro (English)

1 reference

Europe PubMed Central

23 September 2017

author name string

Jane M Turbov

1

1 reference

Europe PubMed Central

23 September 2017

George M Twaddle

2

1 reference

Europe PubMed Central

23 September 2017

Xiaohe Yang

3

1 reference

Europe PubMed Central

23 September 2017

Naxin M Liu

4

1 reference

Europe PubMed Central

23 September 2017

Satya Murthy

5

1 reference

Europe PubMed Central

23 September 2017

publication date

1 January 2002

1 reference

Europe PubMed Central

23 September 2017

Journal of Surgical Oncology

1 reference

Europe PubMed Central

23 September 2017

79

1 reference

Europe PubMed Central

23 September 2017

1

1 reference

Europe PubMed Central

23 September 2017

17-29

1 reference

Europe PubMed Central

23 September 2017

Estrogen replacement therapy in breast cancer survivors. A time for change. Breast Cancer Committees of the Eastern Cooperative Oncology Group.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Estrogen stakes claim to cognition.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Postmenopausal hormone therapy and mortality.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Plasma sex steroid hormone levels and risk of breast cancer in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Hormone replacement therapy in women treated for breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Replacement therapy for breast cancer survivors. A pilot study

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Estrogen-replacement therapy after breast cancer. Risks versus benefits

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

c-Myc or cyclin D1 mimics estrogen effects on cyclin E-Cdk2 activation and cell cycle reentry

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Tyrosine kinase inhibitors targeted to the epidermal growth factor receptor subfamily: role as anticancer agents

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Introduction to steroids in the menopause

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Functional estrogen receptors in a human preosteoclastic cell line

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Bone marrow, cytokines, and bone remodeling. Emerging insights into the pathophysiology of osteoporosis

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Tyrosine kinase inhibition: an approach to drug development

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Specific inhibition of insulin-like growth factor-1 and insulin receptor tyrosine kinase activity and biological function by tyrphostins

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

A specific inhibitor of the epidermal growth factor receptor tyrosine kinase

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Tyrosine kinase inhibitors as antiproliferative agents against an estrogen-dependent breast cancer cell line in vitro

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Granzyme B mimics apical caspases. Description of a unified pathway for trans-activation of executioner caspase-3 and -7.

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Rapid colorimetric assay for cellular growth and survival: Application to proliferation and cytotoxicity assays

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

All-trans retinoic acid (ATRA)-induced apoptosis is preceded by G1 arrest in human MCF-7 breast cancer cells

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Inhibition of Cdk2 activation by selected tyrphostins causes cell cycle arrest at late G1 and S phase

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Epidermal growth factor receptor signaling cascade as target for tyrphostin (RG 50864) in epithelial cells. Paradoxical effects on mitogen-activated protein kinase kinase and mitogen-activated protein kinase activities

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Activation of the estrogen receptor through phosphorylation by mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Estradiol-induced phosphorylation of serine 118 in the estrogen receptor is independent of p42/p44 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Differential cross-talk of estrogen and growth factor receptors in two human mammary tumor cell lines

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

TGF beta in prostate cancer: a growth inhibitor that can enhance tumorigenicity

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Inhibition of the epidermal growth factor receptor family of tyrosine kinases as an approach to cancer chemotherapy: progression from reversible to irreversible inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Status of bcr-abl tyrosine kinase inhibitors in chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

The epidermal growth factor receptor as a target for cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Estrogen replacement therapy and risk of fatal colon cancer in a prospective cohort of postmenopausal women

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Menopausal estrogen replacement therapy in women with breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Constitutive Raf-1 kinase activity in breast cancer cells induces both estrogen-independent growth and apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Tyrphostins. 6. Dimeric benzylidenemalononitrile tyrophostins: potent inhibitors of EGF receptor tyrosine kinase in vitro

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Mechanism of action of a tyrphostin, 3,4-dihydroxy-alpha-cyanothiocinnamamide, in breast cancer cell growth inhibition involves the suppression of cyclin B1 and the functional activity of cyclin B1/p34cdc2 complex

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Blockade of the epidermal growth factor receptor inhibits transforming growth factor alpha-induced but not estrogen-induced growth of hormone-dependent human breast cancer

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Inhibition of platelet activation by tyrosine kinase inhibitors

1 reference

https://api.crossref.org/works/10.1002%2FJSO.10033

21 January 2018

Identifiers

10.1002/JSO.10033

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40761190&oldid=1906747947"